The FDA Advisory Panel recommended Feb. 28 physicians conduct lifelong surveillance for abdominal aortic aneurysm patients who underwent endovascular aortic repair.
Read the full post on Becker's Hospital Review - Healthcare News
FDA suggests ‘lifelong surveillance’ of some aortic aneurysm repairs
